nvn1000
Small moleculeexperimental
Clinical trial activity
7 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01556698)
Timeline
Indications
Mechanism of action
- Nitric oxide synthaseSupplementation
Nitric oxide synthase supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nvn1000
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03431610 | Phase 1 | Nov 13, 2017 | Novan, Inc., Novella Clinical |
| NCT02462187 | Phase 2 | May 1, 2015 | Novan, Inc., PPD |
| NCT01844739 | Phase 1 | Apr 1, 2013 | Novan, Inc. |
| NCT01844752 | Phase 2 | Apr 1, 2013 | Novan, Inc. |
| NCT01755247 | Phase 1 | Nov 1, 2012 | KGL, Inc., Novan, Inc. |
| NCT01694810 | Phase 1 | Sep 1, 2012 | KGL, Inc., Novan, Inc. |
| NCT01556698 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2011 | Novan, Inc. |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novan, Inc. | For profit | 7 | 7 | 2 | 2011 |
| KGL, Inc. | For profit | 2 | 0 | 1 | 2012 |
| Novella Clinical | For profit | 1 | 0 | 1 | 2017 |
| PPD | For profit | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1